J&J Medical Connect
XARELTO®

(rivaroxaban)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

XARELTO - Comparison with Asundexian

Last Updated: 09/28/2026

SUMMARY

  • No head-to-head clinical trials that directly compare the safety and efficacy of XARELTO and asundexian were identified. Therefore, based on the available clinical evidence, no direct comparative conclusions can be drawn regarding the relative safety and efficacy of XARELTO and asundexian.

CLINICAL DATA

A review of the available clinical literature did not identify any head-to-head clinical trials that directly compare the safety and efficacy of XARELTO and asundexian. Consequently, direct comparisons of clinical outcomes between XARELTO and asundexian cannot be made.

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, DERWENT® (and/or other resources, including internal/external databases) was conducted on 17 September 2026.

Would you like to clear and leave your conversation? Message history will be lost.